ECSP961764A - THERAPEUTIC AMIDES - Google Patents
THERAPEUTIC AMIDESInfo
- Publication number
- ECSP961764A ECSP961764A ECSP961764A ECSP961764A EC SP961764 A ECSP961764 A EC SP961764A EC SP961764 A ECSP961764 A EC SP961764A EC SP961764 A ECSP961764 A EC SP961764A
- Authority
- EC
- Ecuador
- Prior art keywords
- compounds
- atherosclerosis
- diseases
- amides
- therapeutic amides
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 201000001320 Atherosclerosis Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 101150102415 Apob gene Proteins 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Esta inevnción se refiere a compuestos que son inhibidores de la secreción de la proteína de transferencia de triglicéridos del micrisima y/o de la apoliproteína B(apoB) y que por lo tanto son útiles para la prevención y tratamiento de la aterosclerosis y sus secuelas clínicas, para la reducción de los serolípidos y para las enfermedades asociadas. La invención se refiere además a las composiciones que incluyen los compuestos y a procedimientos para el tratamiento de la aterosclerosis, obesidad y enfermedades, y/o estados relacionados, con los compuestos.This disclosure refers to compounds that are inhibitors of the secretion of the micrisima triglyceride transfer protein and / or apoliprotein B (apoB) and that are therefore useful for the prevention and treatment of atherosclerosis and its clinical sequelae. , for the reduction of serolipids and for associated diseases. The invention further relates to compositions including the compounds and to methods for treating atherosclerosis, obesity and diseases, and / or related conditions, with the compounds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961764 ECSP961764A (en) | 1996-05-29 | 1996-05-29 | THERAPEUTIC AMIDES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961764 ECSP961764A (en) | 1996-05-29 | 1996-05-29 | THERAPEUTIC AMIDES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP961764A true ECSP961764A (en) | 1997-09-22 |
Family
ID=42042494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP961764 ECSP961764A (en) | 1996-05-29 | 1996-05-29 | THERAPEUTIC AMIDES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP961764A (en) |
-
1996
- 1996-05-29 EC ECSP961764 patent/ECSP961764A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26130A1 (en) | COMPOUNDS TO TREAT OBESITY | |
| BR9502707A (en) | Compound pharmaceutical composition and method for treating a condition | |
| ES2191152T3 (en) | COMBINED THERAPY FOR THE TREATMENT OF PSYCHOSIS. | |
| ES2170104T3 (en) | INHIBITORS OF THE PRODUCTION OF BETA-AMILOID PROTEINS. | |
| ECSP045520A (en) | TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS | |
| BR0012666A (en) | Imidazoimidazoles and triazoles as anti-inflammatory agents | |
| CU23029A3 (en) | BENZOPIRAN REPLACED ANALOGS FOR THE TREATMENT OF INFLAMMATION | |
| ES2165441T3 (en) | INHIBITORS OF CALPAIN AND / OR CATEPSIN B OXAZOLIDIN REPLACED. | |
| DE60327211D1 (en) | THERAPEUTIC COMPOSITIONS FOR USE IN PROPHYLAXIS OR TREATMENT OF CASES | |
| UA26213C2 (en) | MEANS FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITION AND THEIR BASES | |
| CR9465A (en) | PHARMACOCINETICALLY IMPROVED COMPOUNDS | |
| PT971713E (en) | USE OF COLINESTERASE INHIBITORS FOR TREATMENT OF ATENTION DISORDERS | |
| ATE179610T1 (en) | COMPOSITION FOR THE TREATMENT OF OVARIAN ESTROGEN-DEPENDENT DISEASES | |
| SV1995000007A (en) | DERIVATIVES OF 5-SUBSTITUTED MYCOPHENOLIC ACID. | |
| PT705100E (en) | THERAPEUTIC SUBSTITUTED GUANIDINS | |
| ECSP055609A (en) | "Use of IkB-kinase inhibitors for the treatment of pain" | |
| ATE438618T1 (en) | INHIBITORS OF HUMAN ADAM-10 | |
| DK1032556T3 (en) | Pharmaceutically active compounds and methods of use | |
| DE69918972D1 (en) | USE OF NMDA ANTAGONISTS AND / OR SODIUM CHANNEL ANTAGONISTS FOR TREATING INFLAMMABLE DISEASES | |
| ES2164447T3 (en) | BONE RESORTION INHIBITION PROCEDURE. | |
| BR0008603A (en) | Copd treatment method | |
| ES2167721T3 (en) | USE OF 1-HYDROXY-2-PYRIDONS FOR THE TREATMENT OF SEBORRHIC DERMATITIS. | |
| ES2103825T3 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 5-DIFLUOROMETOXI-2- (3,4-DIMETOXI-2-PIRIDIL) -METILSULFINIL) BENCIMIDAZOLE AND AN ANTI-HELICOBACTER AGENT FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS. | |
| ECSP003590A (en) | CALCIOLITIC COMPOUNDS | |
| ES1022449Y (en) | THERAPEUTIC APPARATUS FOR TREATMENT OF SYMPTOMS CAUSED BY DISEASES. |